Practice Areas: Defective Drugs

St. Jude Medical, Inc. Issues Recall of Its Riata and Riata ST Silicone Endocardial Defibrillator Leads

On Nov. 28, 2011, the medical device manufacturer St. Jude Medical, Inc. issued a recall of its Riata and Riata ST Silicone Endocardial defibrillator leads. “Leads” are the wires that connect an implantable cardioverter defibrillator (ICD) to the heart in order to monitor heart rhythms for life-threatening heart rhythms (arrhythmias) and to deliver electrical shocks […]

Read More

Study Finds Zithromax May Carry Higher Risk of Cardiovascular Death

A recent study has caused the FDA to warn that Zithromax antibiotic made by Pfizer Inc. may cause a “small increase” in the risk of cardiovascular death compared with another common antibiotic. The study states that the antibiotic which is used to treat infections, caused a “small absolute increase in cardiovascular deaths” among patients, particularly […]

Read More

Johnson & Johnson Fined $1.2 Billion for Concealing Dangers of Drug

On Wednesday, April 11, 2012, an Arkansas court fined healthcare giant Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, $1.2 billion after a jury found that the companies had minimized or concealed the dangers associated with the drug, Risperdal. The fine was for nearly 240,000 violations of the Arkansas Medicaid fraud law, as well as […]

Read More

Dangerous Drugs: What’s in a Name?

Defective Generic vs. Brand name Drugs: What Your Pharmacists Don’t Tell you. “What’s in a name? that which we call a rose by any other name would smell as sweet.” When Shakespeare penned that line for Juliet about Romeo, he had no idea how wrong he was when it comes to dangerous drugs that slip […]

Read More

Birth Control Pill Recall

Pfizer has voluntarily recalled 14 lots of Lo/Ovral-28 tablets and 14 groups of the generic versions of the pill — one million total pill packs were recalled due to a packaging error. Many women have already been effected by birth control pill recalls in Jacksonville, FL. If you or someone you know has been effected, […]

Read More

F.D.A. Revokes Approval of Avastin
as Breast Cancer Drug

The Food and Drug Administration has announced that it was revoking its approval of the drug Avastin for breast cancer after concluding that it “has not been shown to be safe and effective for that use.” Avastin, made by the pharmaceutical company Roche, will remain an approved treatment for certain types of colon, lung, kidney […]

Read More

FDA Warns Birth Control Pills Yaz, Yasmin and Other Drospirenone Pills: Possible Increase Risk of Blood Clots

FDA Warning – Birth Control Pills Yaz, Yasmin and Other Drospirenone Pills: Possible Increased Risk of Blood Clots The U.S. Food and Drug Administration (FDA) released a Safety Communication reporting that it “remained concerned” about the potential increased risk of blood clots associated with the use of drospirenone-containing birth control pills. Drospirenone is the synthetic […]

Read More

Actos Bladder Cancer Risks

Actos has been used to treat Type 2 diabetes since 2000 and is sometimes prescribed in conjunction with other active ingredients such as insulin, metformin, or glimepiride. It is designed to lower blood glucose levels and thereby increase the patient’s sensitivity to insulin.   More than 2.3 million prescriptions for the drug were issued in […]

Read More

Generic Drugmaker Recalls 1.4 Million Packages of Birth Control Pills

Qualitest Pharmaceuticals, based in Huntsville, Ala., recalled select blister packs of oral contraceptives had been rotated 180 degrees, “reversing the weekly tablet orientation.”  The error could lead to unintended pregnancy, the release said.  Eight products were included in the recall. All eight products are sold as 28-day packs, which include 21 active pills, and seven […]

Read More

National Vaccine Injury Compensation Program (NVICP)

Over 5,000 petitioners have filed suit in the National Vaccine Injury Compensation Program (“NVICP”) alleging vaccines caused autism in their children. Due to similar issues, experts, and discovery for each case, the cases were filed under the Omnibus Autism Proceeding (“OAP”) in the NVICP. The decision was made that six test cases would be tried […]

Read More